For example, tumor cells directly inhibit T cell function by releasing PD-L1 through exosomes, while anti-PD-1 therapy promotes cancer treatment by blocking the PD-1/PD-L1 signaling pathway and reducing the secretion of PD-L1 in exosomes (100). Here, CD274 is linked to neoplasm.